The mechanism underlying thrombosis in atrial fibrillation (AF) is not yet clearly understood. The apelin/ APJ axis parallel and counter-regulate with the angiotensin system. The present study hypothesizes that apelin/ APJ axis exert its anti-thrombus effect in normal left atrial tissue and is disrupted by up-regulated reninangiotensin-aldosterone system (RAAS) signaling during AF. The specimens of left atrial appendages collected from patients with rheumatic mitral stenosis who underwent valve replacement were divided into 3 groups: sinus rhythm, AF 1,2) During AF, thrombus is promoted by blood stasis in poorly contractile atria along with a hypercoagulable state. It is a major independent risk factor with a 5-fold risk of stroke and systemic thromboembolisms.
A trial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. 1, 2) During AF, thrombus is promoted by blood stasis in poorly contractile atria along with a hypercoagulable state. It is a major independent risk factor with a 5-fold risk of stroke and systemic thromboembolisms. 3) Therefore, extensive research efforts have focused on identifying the mechanisms leading to AF-related embolism.
RAAS signaling plays an important role in AF. Angiotensin II (ANG II) and AT1 are associated with the process of atrial electrical remodeling 4) and fibrosis. 5) RAAS inhibition was considered as a cornerstone for the primary and secondary prevention of AF. Furthermore, losartan, a RAAS inhibitor, was reported to have an extra antithrombotic effect in AF treatment. In a clinical study, the patients with left-ventricular hypertrophy and AF benefited from losartan, compared with atenolol, a bblocker, in preventing stroke, even though equivalent blood pressure reductions were provided by both agents. 6) These results suggested the RAAS pathway was involved in hypercoagulable state in AF, but the detailed mechanism was still not clear. APJ is initially identified as the gene with closest homology to AT-1. Its principle effect is to counterbalance RAAS activation. 7) Apelin is an endogenous ligand of the APJ in serum. Apelin and APJ play important roles in the cardiovascular system, including the reduction of blood pressure, the regulation of cardiovascular tone and cardiac contractility. In a cohort of well-characterized patients with lone AF, circulating level of apelin is significantly reduced, 8) indicating its role in the procedure of AF. Besides its role as a natural counterbalance of RAAS, apelin/APJ axis also takes part in anti-thrombus. In apelin-deficient mice, researchers identify that apelin is a key player in hemostasis with an ability to inhibit thrombin-and collagen-mediated platelet activation. 9) Hence, whether low apelin/APJ, which is induced by intense and prolonged RAAS, is a reason for procoagulant situation in AF needs to be further explored.
In the present study, we analyzed the expression of apelin/APJ and downstream PAI-1 in the atrium of pa-tients with valve heart diseases with or without thrombus formation. We observed upregulation of AT1 and downregulation of apelin/APJ in patients with AF and thrombus formation. These results indicated subsequence apelin/APJ alternation was involved in thrombogenesis in AF.
Methods
Study population and tissue specimens: One hundred and 83 patients with valve heart disease (VHDs) who underwent valve replacement were recruited between January 2014 and May 2015 at Nanjing Drum Tower Hospital affiliated to Nanjing University Medical School and Huaian First People's Hospital. All of the 183 patients were stratified into three groups: group A (n = 92, sinus rhythm): AF The thrombus was diagnosed depending on surgeons' finding during operation. 2-dimensional transthoracic echocardiography was performed on all the patients pre-and post-operation. The exclusion criteria of the patients include hyperthyreosis, sick sinus syndrome, and renal disease. All medications were continued before surgery except for warfarin. The operations were performed as described previously. 10) Parts of left atrial appendage specimens were fixed in 4% paraformaldehyde for immunohistochemistry and Masson's trichrome stain. The remaining part was frozen in liquid nitrogen and stored at −80 for western blot.
All procedures involving human tissue collection and analyses were approved by the Institutional Ethics Committee of Nanjing Drum Tower Hospital (Approval No.201446) and Huaian First People's Hospital (Approval No.201431), and performed in accordance with the principles outlined in the Declaration of Helsinke. All participants enrolled in the present study provided written informed consent. Western blot: Tissue samples were homogenized in RIPA buffer containing a 1% proteinase inhibitor cocktail (Roche) on an ice rotator, and then centrifuged at 12,000 rpm for 20 minutes at 4 . The supernatants were subjected to BCA protein assay (Pierce) to estimate the protein concentrations.
Western blot was performed as described previously.
11) Equal protein mixtures were separated in 12% SDS-PAGE and transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% nonfat milk in Tris-buffered saline containing 0.1% Tween 20 (TBST) for 2 hours at room temperature, and then incubated at 4 overnight with the following primary antibodies: anti-apelin (1:200, santa cruz), anti-APJ (1:500, novusbio), anti-AT1 (1:400, abcam) and anti-PAI-1 (1:500, ABsci). Anti-GAPDH (1:5000, Bioword) was used as the loading control. After washing with TBST, the membranes were incubated with horseradish peroxidase-conjugated goat anti-mouse (1:10000, Bioword), goat anti-rabbit (1: 10000, Bioword) or rabbit anti-goat antibodies (1:10000, Bioword) at room temperature for 1 hour. The reactions were developed with enhanced chemiluminescence (Millipore), and images were obtained by film exposure. The bands were quantified using Image J software. All the quantifications of proteins were normalized against GAPDH. Immunohistochemistry : The immunohistochemistry staining was performed as previously described. 12) Human left atrial appendages were fixed in 4% paraformaldehyde overnight, embedded in paraffin and cut into 4 um-thick sections. After deparaffinization, endogenous peroxidase quenching and epitope retrieval, tissue sections were blocked with 1% bovine serum albumin in PBS for 30 minutes and then stained with anti-APJ (novusbio) and anti-AT1 (abcam) overnight at 4 . After washing three times with PBS, slides were incubated with biotinylated secondary antibody for 20 minutes. Staining was visualized using the VectaStain ABC-AP kit. PBS served as a negative control. Statistical analysis: All data were described as mean and standard deviation. All categorical variables were described with absolute and relative frequency distributions. Means of groups were compared by Kruskal-Wallis test. Differences between groups were analyzed using χ 2 test or Fisher's exact test. Statistical analyses were performed using SPSS version 16.0 software (SPSS Inc. Chicago, Illinois). P value < 0.05 was considered statistically significant.
Results

Clinical characteristics:
We recruited 183 patients with VHDs undergoing valve replacement surgery. All patients were divided into three groups: AF Table I ). The clinical data of recruited patients were shown in Table I . Rheumatic heart disease were observed more common in the patients with AF than the patients without AF (71.6% in AF + /thrombus − group and 100% in AF + /Thrombus + group, versus 19.6% in AF − / thrombus − group, P < 0.001). Meanwhile more incidences of pulmonary hypertension, mitral stenosis, mitral regurgitation and tricuspid regurgitation were observed in patients with AF than without AF. Significant differences were also observed in age and New York Heart Association (NYHA) class between patients with and without AF. The AF + /thrombus + and AF + /thrombus − groups were older and had worse NYHA classes than the AF − /thrombus − group (P < 0.01, P < 0.001 respectively). Although PT, APTT and INR were similar in the three groups, the incidence of stroke/transient ischemic attacks (TIA) between groups was significantly different (P = 0.005), AF patients with thrombus had a higher incidence of stroke/TIA. Comorbidities, BUN and Cr were similar among the three groups. Echocardiography parameters: Echocardiography parameters of recruited patients were compared pre-and post-operation. The interventricular septum thickness, leftventricular end-diastolic diameter, postero-lateral wall thickness, and ejection fraction were similar in the three groups in UCG pre-and post-operation (Table II) − group (P < 0.001 and P < 0.05 respectively), which was accompanied by an decrease in the expression of apelin and APJ (P < 0.05) ( Figure 1A ). In the two AF groups, the expression of AT1 is higher in the AF + /thrombus + group as compared to the AF + /thrombus − group (P < 0.05), while the expression of apelin and APJ is lower in the AF + /thrombus + group. To further confirm the alerted levels of AT1 and APJ, we analyzed their expression using immunohistochemical staining ( Figure 1B ). In line with the results of western blot, the results of immunohistochemical staining showed that expression of AT 1 is higher in AF groups and APJ is lower in the AF + groups than in the AF − group. Meanwhile, we assessed tissue fibrosis by Masson stain. As shown in Figure 1B The result of statistical analysis for the three groups *P < 0.05 between groups, ***P < 0.001 between groups. AF -/thrombus -, n = 92; AF + /thrombus -, n = 74; AF + /thrombus + , n = 17. T indicates thrombus.
apelin/APJ axis and reported to promote the thrombus formation in other organs. As shown in Figure 2A , PAI-1 was highly expressed in the atrium with AF, when compared with patients without AF (P < 0.05). PAI-1 was further up-regulated in specimens from AF patients with thrombus formation (P < 0.05). Immunohistochemical staining of PAI-1 is consistent with the result of western blot ( Figure 2B ).
Discussion
The major finding of the present study is that the expression of apelin/APJ axis is associated with the thrombogenesis in VHD patients with AF. The anti-thrombus ef-APELIN/APJ IN ATRIAL FIBRILLATION PATIENTS fect of apelin/APJ axis may come from its downstream PAI-1, which is reportedly the key factor in the process of thrombus formation.
Apelin gene has been demonstrated to be expressed in many tissues including the atrium in adult vertebrates.
13)
The APJ receptor is expressed in the developing heart tubes and vasculature, adult endothelium, atrial endocardium. The expression of apelin/APJ axis parallels the angiotensin system. They are involved in similar processes and counter-regulated with each other. 14) In a previous study, circulating apelin levels were found to be significantly lower in subjects with lone AF when compared with controls. 8) Here, we further observed the expression of apelin decreases in VHD patients with AF compared with patients without AF in left atrium, least expressed in the AF + /thrombus + group. The expression of APJ showed the same tendency. All these results indicated that apelin/ APJ axis was involved in the pathological procedure of AF and thrombus formation in AF.
PAI-1 was important downstream of apelin/APJ axis, which is a procoagulant factor, promoting the deposition of fibrin and platelet activation, secretion and aggregation. 15, 16) In vitro studies revealed that apelin could block PAI-1 gene expression through a luciferase reporter assay. In detail, apelin reduced phosphorylation of myosin phosphatase subunit (MYPT) and myosin light chain in the Rho-kinase pathway, which is associated with PAI-1 gene expression. 5) Here the expression of PAI-1 is highest in patients with AF and thrombus and is contrary to the expression of apelin/APJ in the left atrium. Therefore, we speculated that apelin/APJ interfered with thrombinmediated signaling pathways by inhibiting PAI-1 in normal LA tissue. This physiological anti-thrombus mechanism was disrupted during AF via up-regulated RAAS pathway.
Previous studies indicated that angiotensin converting enzyme inhibitors (ACE-Is) and AT1 receptor antagonists (AT1-As) showed antithrombotic effects in both venous and arterial thrombosis models. 17, 18) Further experiments indicated that Ang II affects various elements of hemostasis. Ang II could induce oxidative stress, 19) inhibit nitric oxide synthesis 20) and enhance leukocytes infiltration and adhesion 21) to vascular walls, leading to endothelial dysfunction. Ang II can also augment blood platelet activation. 22) In this study, we indicated the effect on apelin/APJ axis was also a mechanism in AngII induced thrombus formation in AF. Further work for more detailed mechanisms could be carried out in the future.
Conclusions
Apelin/APJ axis may play a key role in atrial thrombogenesis in VHD patients with AF. Limitation: The researchers admit this current work is based on a small number of patients, making it difficult to draw a more accurate conclusion. More advanced trials with longer follow-up and larger sample sizes are needed for the prognosis potential of apelin/APJ expression in thrombosis. It is hardly clear that there is a causal relationship between the up-regulated Ang II and downregulated apelin. The possible interaction between Ang II expression and apelin/APJ axis needs to be investigated further.
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